Lasmiditan succinate is a pharmaceutical raw material used in the manufacturing of medications for migraine. It is taken orally and is not intended for migraine prevention.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Lasmiditan succinate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Lasmiditan hydrochloride
pharmaceutical raw material
Lasmiditan
pharmaceutical raw material
Niflumic acid
pharmaceutical raw material
Eribulin mesylate
pharmaceutical raw material
Macitentan
pharmaceutical raw material
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-(4-chlorophenyl)-4-pyrimidinyl]-N'-propyl-
pharmaceutical raw material
butanedioic acid;bis(2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridinyl]benzamide)
MSOIHUHNGPOCTH-UHFFFAOYSA-N
CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F.CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F.C(CC(=O)O)C(=O)O
Sourcing Lasmiditan succinate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.